Patent Assignment
Reel/Frame 012840/0724
Assignment of Assignor's Interest
Recorded: 2002-04-22
Pages: 3
Assignor
INEX PHARMACEUTICALS CORPORATION
Executed: 2002-04-11
Assignee
PROTIVA BIOTHERAPEUTICS INC.
GLENLYON BUSINESS PARK, 150-8900 GLENLYON PARKWAY, BURNABY B.C., V5J 5, CANADA
Covered Properties
(3)
Systemic Delivery of Serum Stable Plasmid Lipid Particles for Cancer Therapy
Application:
09/243,102 →
Combination Therapy Using Nucleic Acids and Conventional Drugs
Patent:
6,841,537 →
Application:
09/295,663 →
Combination Therapy Using Nucleic Acids and Radio Therapy
Patent:
6,841,538 →
Application:
09/295,925 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 25, 1999
From: JOSHI, PHALGUN B.; MORTIMER, IAN C.; TAM, PATRICK M.S.; MACLACHLAN, IAN
To: INEX PHARMACEUTICALS CORPORATION
Reel/Frame 010118/0133 →
Assignment of Assignor's Interest
Sep 13, 1999
From: DURAND, RALPH E.
To: BRITISH COLUMBIA CANCER AGENCY
Reel/Frame 010232/0951 →
Assignment of Assignor's Interest
Sep 13, 1999
From: JOSHI, PHALGUN B.; GRAHAM, ROGER W.
To: INEX PHARMACEUTICALS CORPORATION
Reel/Frame 010232/0954 →
Security Agreement
Dec 29, 2011
From: PROTIVA BIOTHERAPEUTICS, INC.
To: SILICON VALLEY BANK
Reel/Frame 027463/0613 →
Merger
Feb 20, 2018
From: PROTIVA BIOTHERAPEUTICS INC.
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 045384/0278 →
Release of Security Interest
Feb 16, 2023
From: SILICON VALLEY BANK
To: PROTIVA BIOTHERAPEUTICS, INC.
Reel/Frame 062721/0199 →